Stay updated on Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T13:12:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    403 Forbidden error is shown when accessing the study record, replacing the previous study content. This prevents users from viewing the trial details, documents, or locations.
    Difference
    19%
    Check dated 2026-09-24T18:27:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a new Revision: v3.7.0 tag, replacing the previous Revision: v3.6.6, indicating the content was updated to a newer version.
    Difference
    0.0%
    Check dated 2026-09-17T20:02:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling deployment of a new build rather than content changes.
    Difference
    0.0%
    Check dated 2026-09-03T16:55:55.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier was added to the study's identifiers, indicating NIH funding/contract support for the REACH3 trial.
    Difference
    0.0%
    Check dated 2026-08-27T15:50:58.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now records revision v3.6.5, replacing the previous v3.6.4. This indicates a small maintenance update rather than a substantive change to page content.
    Difference
    0.0%
    Check dated 2026-08-13T10:52:44.000Z thumbnail image

Stay in the know with updates to Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.